CAPS Rating

strk2012 (< 20)

Results 1 - 20 of 40 : 1 2 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
18/01/2013 ICAD.US 4 out of 5 Outperform 5Y $5.30 $5.96 (+2.23%) +12.45% +12.01% +0.45
18/01/2013 CHMT.US 3 out of 5 Outperform 5Y $23.80 $22.56 (+1.99%) -5.21% +12.01% -17.22
18/01/2013 BBSI.US 4 out of 5 Outperform 5Y $41.27 $59.42 (-0.07%) +43.99% +12.01% +31.98
18/01/2013 ADUS.US 5 out of 5 Outperform 5Y $8.60 $20.35 (+3.67%) +136.63% +12.01% +124.62
18/01/2013 DDD.US 4 out of 5 Outperform 5Y $42.45 $47.78 (-0.89%) +12.56% +12.01% +0.56
15/01/2013 ARRS.US 5 out of 5 Outperform 5Y $16.61 $14.89 (+2.34%) -10.38% +12.78% -23.17
15/01/2013 SYMC.US 3 out of 5 Outperform 5Y $20.60 $22.73 (+1.79%) +10.36% +12.78% -2.43
15/01/2013 SGMO.US 2 out of 5 Outperform 5Y $8.60 $8.18 (+2.38%) -4.88% +12.87% -17.75
15/01/2013 MS.US 3 out of 5 Outperform 5Y $20.26 $26.32 (+0.42%) +29.92% +13.04% +16.88
15/01/2013 FB.US 2 out of 5 Outperform 5Y $31.11 $24.21 (+0.78%) -22.18% +13.05% -35.23
13/02/2012 NUAN.US 5 out of 5 Outperform 5Y $27.29 $19.04 (+1.01%) -30.23% +22.48% -52.71
26/01/2012 MNKD.US 2 out of 5 Outperform 5Y $3.38 $6.61 (-12.40%) +95.47% +25.84% +69.63
12/01/2012 SHLD.US 1 out of 5 Underperform 5Y $30.99 $47.06 (+0.47%) +51.86% +27.91% -23.94
05/01/2012 SD.US 4 out of 5 Outperform 5Y $8.70 $4.97 (-1.19%) -42.86% +29.61% -72.47
05/01/2012 DNDN.US 2 out of 5 Outperform 5Y $11.00 $4.08 (-0.49%) -62.91% +30.21% -93.12
19/09/2011 SXI.US 4 out of 5 Outperform 5Y $35.21 $54.63 (+3.37%) +55.16% +38.66% +16.51
19/09/2011 ACTG.US 4 out of 5 Outperform 5Y $45.26 $24.60 (+0.12%) -45.65% +38.66% -84.31
19/09/2011 HBIO.US 5 out of 5 Outperform 5Y $4.71 $5.06 (+1.61%) +7.43% +38.66% -31.22
19/09/2011 INFN.US 5 out of 5 Outperform 5Y $8.16 $11.18 (+1.82%) +37.01% +38.66% -1.65
08/09/2011 CSCO.US 4 out of 5 Outperform 5Y $15.68 $24.82 (+0.49%) +58.29% +37.72% +20.57
Results 1 - 20 of 40 : : 1 2 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.